Cost-effectiveness of continuous positive airway pressure therapy for obstructive sleep apnea: health care system and societal perspectives
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Study Objectives: To determine cost-effectiveness of continuous positive airway pressure (CPAP) treatment of obstructive sleep apnea (OSA) in Australia for 2017–2018 to facilitate public health decision-making. Methods: Analysis was undertaken of direct per-person costs of CPAP therapy (according to 5-year care pathways), health system and other costs of OSA and its comorbidities averted by CPAP treatment (5-year adherence rate 56.7%) and incremental benefit of therapy (in terms of disability-adjusted life years [DALYs] averted) to determine cost-effectiveness of CPAP. This was expressed as the incremental cost-effectiveness ratio (= dollars per DALY averted). Direct costs of CPAP were estimated from government reimbursements for services and advertised equipment costs. Costs averted were calculated from both the health care system perspective (health system costs only) and societal perspective (health system plus other financial costs including informal care, productivity losses, nonmedical accident costs, deadweight taxation and welfare losses). These estimates of costs (expressed in US dollars) and DALYs averted were based on our recent analyses of costs of untreated OSA. Results: From the health care system perspective, estimated cost of CPAP therapy to treat OSA was $12 495 per DALY averted while from a societal perspective the effect was dominant (−$10 688 per DALY averted) meaning it costs more not to treat the problem than to treat it. Conclusions: These estimates suggest substantial community investment in measures to more systematically identify and treat OSA is justified. Apart from potential health and well-being benefits, it is financially prudent to do so.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“They included the impact of estimated healthcare cost savings from reduced medical morbidity ($76 AUD/year).”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [139]
In the citing paper
“In a recent Australian cost effectiveness analysis (CEA), the average annual cost over 5 years for diagnosis and treatment of OSA using lab-based study was estimated at $579 Australian dollars (AUD; $495 US dollars).139”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [139]
In the citing paper
“More recently, Streatfeild et al. estimated that from a healthcare system perspective, the estimated cost to treat OSA was $12,495 AUD (US $8746) per disability adjusted life year (Equivalent to QALY gained).139”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [139]
In the citing paper
“From a societal perspective, there was net cost saving of $326/year because of a projected $783/year cost saving due to the reduction of financial costs (due to gains in productivity, fewer accidents, and other savings).”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [139]
Citations
Cites
Marin, J. M., Carrizo, S. J., Vicente, E., & Agusti, A. G. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71141-7 · Cited by 4,678
Adult Obstructive Sleep Apnea Task Force of the American Academy of Sleep Medicine, Epstein, L. J., Kristo, D., Strollo, P. J., Friedman, N., Malhotra, A., Patil, S. P., Ramar, K., Rogers, R., Schwab, R. J., et al. (2009) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.27497 · Cited by 3,360
Gottlieb, D. J., Yenokyan, G., Newman, A. B., O'Connor, G. T., Punjabi, N. M., Quan, S. F., Redline, S., Resnick, H. E., Tong, E. K., Diener-West, M., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.901801 · Cited by 1,551
Obstructive Sleep Apnea–Hypopnea and Incident Stroke: The Sleep Heart Health Study
Redline, S., Yenokyan, G., Gottlieb, D. J., Shahar, E., O'Connor, G. T., Resnick, H. E., Diener-West, M., Sanders, M. H., Wolf, P. A., Geraghty, E. M., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200911-1746oc · Cited by 1,269
Continuous positive airways pressure for obstructive sleep apnoea in adults
Giles, T., Lasserson, T., Smith, B., White, J., Wright, J., & Cates, C. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001106.pub2 · Cited by 1,001
(2015) · PubMed Central · doi:10.3978/j.issn.2072-1439.2015.06.11 · Cited by 980
Long-term Use of CPAP Therapy for Sleep Apnea/Hypopnea Syndrome
McARDLE, N., DEVEREUX, G., HEIDARNEJAD, H., ENGLEMAN, H. M., MACKAY, T. W., & DOUGLAS, N. J. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.4.9807111 · Cited by 820
Underdiagnosis of Sleep Apnea Syndrome in U.S. Communities
Kapur, V., Strohl, K. P., Redline, S., Iber, C., O'Connor, G., & Nieto, J. (2002) · Sleep And Breathing · doi:10.1055/s-2002-32318 · Cited by 475
Improving CPAP use by patients with the sleep apnoea/hypopnoea syndrome (SAHS)
Engleman, H. M., & Wild, M. R. (2003) · Sleep Medicine Reviews · doi:10.1053/smrv.2001.0197 · Cited by 473
Underdiagnosis of Sleep Apnea Syndrome in U.S. Communities
Kapur, V. K., Strohl, K. P., Redline, S. S., Iber, C., O’Connor, G. T., & Nieto, F. J. (2002) · Sleep And Breathing · doi:10.1007/s11325-002-0049-5 · Cited by 433
Research works printed but not linked: 1
- Cistulli, 2018, Real world PAP adherence: results from a big data approach in more than two million patients, A4391
Cited by
Global burden of sleep‐disordered breathing and its implications
Lyons, M. M., Bhatt, N. Y., Pack, A. I., & Magalang, U. J. (2020) · Respirology · doi:10.1111/resp.13838 · Cited by 422
International Consensus Statement on Obstructive Sleep Apnea
Chang, J. L., Goldberg, A. N., Alt, J. A., Mohammed, A., Ashbrook, L., Auckley, D., Ayappa, I., Bakhtiar, H., Barrera, J. E., Bartley, B. L., et al. (2023) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23079 · Cited by 350
The social and economic cost of sleep disorders
Streatfeild, J., Smith, J., Mansfield, D., Pezzullo, L., & Hillman, D. (2021) · Sleep · doi:10.1093/sleep/zsab132 · Cited by 158
Self-citationDarden, M., Espie, C. A., Carl, J. R., Henry, A. L., Kanady, J. C., Krystal, A. D., & Miller, C. B. (2021) · Sleep · doi:10.1093/sleep/zsaa223 · Cited by 66
May, A. M., Patel, S. R., Yamauchi, M., Verma, T. K., Weaver, T. E., Chai‐Coetzer, C. L., Thornton, J. D., Ewart, G. W., Showers, T., Ayas, N., et al. (2023) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202210-1846st · Cited by 53
Metadata
- Authors
- Streatfeild, J., Hillman, D., Adams, R., Mitchell, S., & Pezzullo, L.
- Affiliations
- Health Economics and Social Policy, Deloitte Access Economics, Canberra, Australia
- The University of Western Australia (AU)
- The University of Adelaide (AU)
- Corresponding author
- Hillman, David
- Venue
- Sleep
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-08-12
- Volume
- 42
- Issue
- 12
- ISSN
- 0161-8105 (ISSN-L)
- 1550-9109
- OpenAlex
- W2968980057
- Semantic Scholar
- 37b9c9d8309f96399e8c9faeb94b26edde333d23
- Cited by
- 51
- References
- 52
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 5 · 2023: 6 · 2022: 9 · 2021: 9 · 2020: 12 · 2019: 1
- FWCI
- 5.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- SLEEP (publishedVersion)
- PubMed (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Funders
- Sleep Health Foundation
- Topics
- Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Keywords
- obstructive sleep apnea, continuous positive airway pressure, CPAP adherence, cost-effectiveness, disability-adjusted life years, social costs, health care costs, productivity loss, informal care, welfare loss, Australia
- MeSH terms
- Australia, Cost-Benefit Analysis, Delivery of Health Care, Follow-Up Studies, Humans, Quality-Adjusted Life Years, Sleep Apnea, Obstructive, Continuous Positive Airway Pressure, Social Norms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cost-effectiveness of continuous positive airway pressure therapy for obstructive sleep apnea: health care system and societal perspectives. https://app.cochat.ai/papers/10.1093/sleep/zsz181
- The paper
- Streatfeild, J., Hillman, D., Adams, R., Mitchell, S., & Pezzullo, L. (2019). Cost-effectiveness of continuous positive airway pressure therapy for obstructive sleep apnea: health care system and societal perspectives. Sleep. https://doi.org/10.1093/sleep/zsz181
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.